Longevica Pharmaceuticals, Inc.

Monmouth Junction, NJ 08852

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $444K
First Award Date 08/01/14
Most Recent Award Date 06/10/15

Key Personnel

Last Name Name Awards Contact
RYAZANOV ALEXEY G. RYAZANOV 2

2 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 06/10/15 - 05/31/16

DESCRIPTION (provided by applicant): Eukaryotic elongation factor 2 protein kinase (eEF2K) is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an "atypical" kinase domain. Our recent findings demonstrate that inhibition or genetic inactivation of eEF2K protects normal tissues from cytotoxic effects of i...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 08/01/14 - 07/01/15

DESCRIPTION (provided by applicant): Eukaryotic elongation factor 2 protein kinase (eEF2K) is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an "atypical" kinase domain. Our recent findings demonstrate that inhibition or genetic inactivation of eEF2K protects normal tissues from cytotoxic effects of c...